Researchers from the IBB-UAB have developed a new class of nanostructures capable of trapping and neutralizing large ...
NIH-funded research offers evidence on transplantation practices that are currently confined to research environments. A ...
Researchers at the Institute for Biotechnology and Biomedicine at the Universitat Autònoma de Barcelona (IBB-UAB) have ...
Proof-of-Concept Study to Find Functional Cure for HIV July 24, 2024 — Researchers conducted a breakthrough proof-of-concept study that found an HIV-like virus particle that could cease the need ...
Matica Biotechnology (Matica Bio), a leading contract development and manufacturing organization (CDMO) for viral vectors, ...
Leerink Partners analyst David Risinger maintained a Hold rating on HilleVax, Inc (HLVX – Research Report) on November 7 and set a price ...
In a report released today, Matthew Caufield from H.C. Wainwright reiterated a Hold rating on HilleVax, Inc (HLVX – Research Report), ...
It develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company was formerly known as ...